J Korean Orthop Assoc.  2009 Oct;44(5):526-532. 10.4055/jkoa.2009.44.5.526.

Total Hip Arthroplasty in Patients with Diabetes Mellitus

• Suh KT
• Lee HS
• Kim MS
• Lee JS
• Kim JI

• KMID: 2186312
• DOI: http://doi.org/10.4055/jkoa.2009.44.5.526

Abstract

PURPOSE
The purpose of present study is to analyze the incidence and the predisposing factors for postoperative complications that diabetes mellitus (DM) patients suffer after undergoing total hip arthroplasty. MATERIALS AND METHODS: Among the 379 patients who underwent primary cementless total hip arthroplasty from September 1998 to February 2007, fifty-nine patients (62 hips) who had DM were selected and the other 320 patients (378 hips) without DM were set as a control group to perform comparative analysis. The mean follow up period was 36 months (range, 12-117 months) and the mean age of patients was 55.5 years (range, 16-79 years). The preoperative and annual postoperative Harris Hip Score (HHS) and the postoperative complications were checked. We analyzed the factors that were associated with the incidence of postoperative complications in DM patients. RESULTS: The DM group had a higher incidence of urinary tract infection and a longer admission period than did non-DM group (p=0.001 and p=0.002). The HHS was 52 and 53 (p=0.185), respectively, for the DM patients and the non-DM patients preoperatively, and it was 93 and 95 (p=0.467), respectively, at the last follow up. The predisposing factors for postoperative complications in DM patients are a high hemoglobin A1c (HbA1c) level and comorbidities. CONCLUSION: Total hip arthroplasty in DM patients is associated with a higher incidence of postoperative complications and a prolonged admission period. A high HbA1c level and comorbidities are considered to have significant associations with these complications.

Keyword

Diabetes mellitus; Total hip arthroplasty; Complications

MeSH Terms

Arthroplasty
Comorbidity
Diabetes Mellitus
Follow-Up Studies
Hemoglobins
Hip
Humans
Incidence
Postoperative Complications
Urinary Tract Infections
Hemoglobins

Reference

1. Centers for Disease Control: National Diabetes Fact Sheet. Division of Diabetes Translation: National Center for Chronic Disease Prevention and Health Promotion. 2002. Atlanta: Centers for Disease Control and Prevention.

2. The committee on the epidemiology of diabetes mellitus. Korean Diabetes Association. The epidemiology of diabetes mellitus in Korea. 2005.

3. Fitzgerald RH Jr, Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA 2nd, Coventry MB. Deep wound sepsis following total hip arthroplasty. . J Bone Joint Surg Am. 1977. 59:847–855.

4. Glynn MK, Sheehan JM. The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin Orthop Relat Res. 1984. 185:151–154.

5. Goodson WH 3rd, Hung TK. Studies of wound healing in experimental diabetes mellitus. J Surg Res. 1977. 22:221–227.

6. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. 1999. 341:1906–1912.

7. Bolognesi MP, Marchant MH Jr, Viens NA, Cook C, Pietrobon R, Vail TP. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty. 2008. 23:Suppl. 92–98.

8. Moeckel B, Huo MH, Salvati EA, Pellicci PM. Total hip arthroplasty in patients with diabetes mellitus. J Arthroplasty. 1993. 8:279–284.

9. Vannini P, Ciavarella A, Olmi R, et al. Diabetes as pro-infective risk factor in total hip replacement. Acta Diabetol Lat. 1984. 21:275–280.

10. Kurzweil PR. Antibiotic prophylaxis for arthroscopic surgery. Arthroscopy. 2006. 22:452–454.

11. Jahoda D, Nyc O, Pokorný D, Landor I, Sosna A. Antibiotic treatment for prevention of infectious complications in joint replacement. Acta Chir Orthop Traumatol Cech. 2006. 73:108–114.

12. Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res. 1988. 232:210–216.

13. Menon TJ, Thjellesen D, Wroblewski BM. Charnley low-friction arthroplasty in diabetic patients. J Bone Joint Surg Br. 1983. 65:580–581.

14. Michelson JD, Lotke PA, Steinberg ME. Urinary-bladder management after total joint-replacement surgery. N Engl J Med. 1988. 319:321–326.

15. England SP, Stern SH, Insall JN, Windsor RE. Total knee arthroplasty in diabetes mellitus. Clin Orthop Relat Res. 1990. 260:130–134.

16. Sutherland CJ, Schurman JR. Complications associated with warfarin prophylaxis in total knee arthroplasty. Clin Orthop Relat Res. 1987. 219:158–162.

17. Drennan DB, Fahey JJ, Maylahn DJ. Important factors in achieving arthrodesis of the Charcot knee. J Bone Joint Surg Am. 1971. 53:1180–1193.

18. Einhorn TA, Boskey AL, Gundberg CM, Vigorita VJ, Devliu VJ, Beyer MM. The mineral and mechanical properties of bone in chronic experimental diabetes. J Orthop Res. 1988. 6:317–323.

19. Alvin CP. Dennis LK, Eugene B, Anthony SF, editors. Diabetes mellitus. Harrison's principles of internal medicine. 2004. 16th ed. New York: McGraw-Hill;2152–2180.

20. O'sullivan CJ, Hynes N, Mahendran B, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patient. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg. 2006. 32:188–197.